Citation
Lok, Anna S.; Zoulim, Fabien; Locarnini, Stephen; Bartholomeusz, Angeline; Ghany, Marc G.; Pawlotsky, Jean-Michel; Liaw, Yun-Fan; Mizokami, Masashi; Kuiken, Carla (2007)."Antiviral drug-resistant HBV: Standardization of nomenclature and assays and recommendations for management Potential conflict of interest: Dr. Lok receives research support and serves on advisory board of GlaxoSmithKline, Gilead, Bristol Myers Squibb, Idenix, Roche Molecular Diagnostics and Innogenetics. Dr. Zoulim serves on advisory board of Gilead, Idenix, Bristol Myers Squibb, Innogenetics and receives research support from bioMerieux. Dr. Locarnini receives research support and serves on advisory board of Gilead Sciences, Bristol-Myers Squibb, Pharmasset, LG Sciences, Innogenetics and Evivar Pty Ltd. Dr. Bartholomeusz is a Consultant to Evivar Medical Pty Ltd. Dr. Pawlotsky receives research support and/or serves on advisory board of GlaxoSmithKline, Gilead, Bristol-Myers Squibb, Idenix and Novartis. Dr. Liaw receives research support and serves on advisory board and speaker bureau of Roche, Bristol-Myers Squibb, GlaxoSmithKline, and Idenix. ." Hepatology 46(1): 254-265. <http://hdl.handle.net/2027.42/56065>
Publisher
Wiley Subscription Services, Inc., A Wiley Company